The tem of the project has a valid contract with the pharmaceutical company LEK for 14N NQR measurements on pharmaceuticals. These measurements are being done with the newly developed spectrometer. This spectrometer, has a significant advantage over our previous approach, as we find frequencies much faster, and can therefore concentrate on making more accurate measurements. Alhough we have been working together with the company even before this project, this was somehow problematic, as it took us a lot of time to find the resonances, which are not their primary interest. For all analysis adequate reports have been written.
F.11 Development of a new service
A member of the project team was one of the editors of konference proceedings which was devoted primarily to the detection with 14N NQR. All major groups working in the field of 14N NQR attended the conference.
C.01 Editorial board of a foreign/international collection of papers/bookCOBISS.SI-ID: 27008551